AIIMS unable to find volunteers for phase-3 trial of Bharat Biotech’s Covaxin
New Delhi: The AIIMS here is unable to find the required number of volunteers for the phase-3 trial of Bharat ...
Read moreNew Delhi: The AIIMS here is unable to find the required number of volunteers for the phase-3 trial of Bharat ...
Read moreNew Delhi: An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought Wednesday additional safety and efficacy data ...
Read moreNew Delhi: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech applied Monday to the central drug regulator seeking ...
Read moreBhubaneswar: The Odisha government Wednesday slashed the price of RT-PCR tests for detection of COVID-19 at private laboratories to Rs ...
Read moreBengaluru: The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi ...
Read moreNew Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here Thursday. ...
Read moreNew Delhi: India’s COVID-19 caseload surpassed the 90-lakh mark Friday with 45,882 new cases the Union Health Ministry said. The ...
Read moreHyderabad: Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech Monday ...
Read moreNew Delhi: The Serum Institute of India (SII) and the Indian Council of Medical Research (ICMR) Thursday announced the completion ...
Read moreNew Delhi: The Bacille Calmette-Guerin or BCG vaccine, originally made against tuberculosis, may help in the management of Covid-19, especially ...
Read more